title: Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenström macroglobulinemia: final analysis of a phase 2 study.
authors.affiliation: Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
authors.forename: Efstathios
authors.initials: E
authors.lastname: Kastritis
authors.affiliation: Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
authors.forename: Maria
authors.initials: M
authors.lastname: Gavriatopoulou
authors.affiliation: First Department of of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
authors.forename: Marie-Christine
authors.initials: MC
authors.lastname: Kyrtsonis
authors.affiliation: Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
authors.forename: Maria
authors.initials: M
authors.lastname: Roussou
authors.affiliation: Theageneion Cancer Center, Thessaloniki, Greece.
authors.forename: Evdoxia
authors.initials: E
authors.lastname: Hadjiharissi
authors.affiliation: Department of Hematology, University of Patras School of Medicine, Patras, Greece.
authors.forename: Argyris
authors.initials: A
authors.lastname: Symeonidis
authors.affiliation: Metaxa Cancer Center, Piraeus, Greece.
authors.forename: Panagiotis
authors.initials: P
authors.lastname: Repoussis
authors.affiliation: Department of Hematology, G. Genimatas Hospital, Athens, Greece.
authors.forename: Evridiki
authors.initials: E
authors.lastname: Michalis
authors.affiliation: Department of Hematology and Bone Marrow Transplant, Evangelismos Hospital, Athens, Greece.
authors.forename: Sosana
authors.initials: S
authors.lastname: Delimpasi
authors.affiliation: School of Medicine, Democritus University of Thrace, Alexandroupolis, Greece.
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Tsatalas
authors.affiliation: Second Department of Internal Medicine, National and Kapodistrian University of Athens, Haidari, Greece.
authors.forename: Panagiotis
authors.initials: P
authors.lastname: Tsirigotis
authors.affiliation: Department of Hematology, University of Ioannina School of Medicine, Ioannina, Greece.
authors.forename: Amalia
authors.initials: A
authors.lastname: Vassou
authors.affiliation: Henry Dunant Hospital, Athens, Greece.
authors.forename: Elina
authors.initials: E
authors.lastname: Vervessou
authors.affiliation: Theageneion Cancer Center, Thessaloniki, Greece.
authors.forename: Eirini
authors.initials: E
authors.lastname: Katodritou
authors.affiliation: Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
authors.forename: Dimitra
authors.initials: D
authors.lastname: Gika
authors.affiliation: Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
authors.forename: Evangelos
authors.initials: E
authors.lastname: Terpos
authors.affiliation: Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
authors.forename: Meletios A
authors.initials: MA
authors.lastname: Dimopoulos
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage; D018450:Disease Progression; D018572:Disease-Free Survival; D006801:Humans; D008875:Middle Aged; D000069283:Rituximab / Q000008:administration & dosage; D016896:Treatment Outcome; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy
chemical_list: D000069283:Rituximab; D003907:Dexamethasone; D003520:Cyclophosphamide